APJ agonist nanobody therapeutics (BioAge Labs)

N/A

Report date: 2025/06/27 14:45:01

Base Information

Drug NameAPJ agonist nanobody therapeutics (BioAge Labs)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionApelin receptor agonists
TargetsApelin receptor
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghaiTech University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jikang Biotechnology Co Ltd.BioAge Labs Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A